5-amino-1mq is unique in its NNMT inhibition approach
Current statistics indicate that fewer than 10% of those diagnosed with AUD receive any form of treatment, and only 2% of those who do utilize evidence-based pharmacotherapy
Cignas 2026 commercial formulary includes six GLP-1 medications: Wegovy (semaglutide for obesity and CVD), Zepbound (tirzepatide for obesity and OSA), Ozempic (semaglutide for type 2 diabetes), Mounjaro (tirzepatide for type 2 diabetes), Saxenda (liraglutide for obesity), and Rybelsus (oral semaglutide for type 2 diabetes)
Phase 2 study examining magnesium-dependent tinnitus
Instead, they seem built to help startups, med spas, wellness brands, and developing beauty businesses move from idea to product in a way that feels structured, compliant, and commercially realistic
Glucagon-like peptide-1 (GLP-1) is a hormone integral to regulating blood sugar levels and influencing appetite and digestion